Fizikalna terapija poboljšava kretanje kod bolesnika sa miozitisom praćenim inkluzionim telima

  • Jelena B Stevanović Univerzitet u Kragujevcu, Fakultet medicinskih nauka,Odeljenje za fizikalnu medicinu i rehabilitacij.
  • Maja Vulović University of Kragujevac, Faculty of Medical Sciences, Department of Anatomy
  • Danijela Pavićević Military Medical Academy, Department of Physical Medicine and Rehabilitation
  • Mihailo Bezmarević Military Medical Academy, Clinic for General Surgery
  • Anđelka Stojković University of Kragujevac, Faculty of Medical Sciences, Department of Pediatrics
  • Aleksandar Radunović Military Medical Academy, Clinic for Orthopedic Surgery
  • Miljana Aksić University of Kragujevac, Faculty of Medical Sciences, Kragujevac
  • Bojan Milošević University of Kragujevac, Faculty of Medical Sciences, Department of Surgery
  • Aleksandar Cvetković Clinical Center Kragujevac, General and Thoracic Surgery Department
  • Milan Jovanović Clinical Center Kragujevac, Department of Physical Medicine and Rehabilitation
  • Anita Ivošević University of Kragujevac, Faculty of Medical Sciences Department of Internal Medicine, Kragujevac
DOI: https://doi.org/10.2298/VSP171110165S
Ključne reči: miozitis sa inkluzionim telima;, mišićna slabost;, fizikalna terapija;, biopsija;, dijagnoza;, lečenje, ishod

Sažetak


Uvod. Miozitis sa inkluzionim telima (IBM) je redak oblik inflamatorne miopatije koja ima sporo progresivan tok. Manifestuje se ranom slabošću i atrofijom skeletne muskulature, posebno mišića podlaktice i kvadricepsa. Na samom početku bolesti, klinički simptomi nisu izraženi, pa je postavljanje dijagnoze teško. Prikaz bolesnika. Bolesnica stara 48 godina javila se lekaru zbog slabosti u mišićima ruku i nogu. Prethodnih pet godina je u više navrata lečena od strane neurologa i fizijatra sa različitim dijagnozama progresivne mišićne slabosti. Tokom poslednje hospitalizacije, IBM je dijagnostikovan nakon biopsije mišića. Nakon uspostavljene dijagnoze, bolesnica je prošla intenzivnu fizikalnu terapiju kako bi se očuvala sposobnost samostalnog obavljanja svakodnevnih aktivnosti i stabilnost hoda. Zaključak. IBM predstavlja redak klinički entitet kod koga često prođe i više godina do postavljanja dijagnoze. Progresivana slabost mišića kod starjih osoba treba da ukaže na moguću dijagnozu IBM, koja se jedino potvrđuje biopsijom mišića. Fizikalna terapija ima značajnu ulogu u lečenju jer dovodi do poboljšanja funkcionalnih sposobnosti bolesnica u aktivnostima dnevnog života čime se smanjuje stepen invalidnosti.

 

Reference

Vattemi G, Mirabella M, Guglielmi V, Lucchini M, Tomelleri G, Ghirardello A, et al. Muscle biopsy features of idiopathic in-flammatory myopathies and differential diagnosis. Auto Immun Highlights 2014; 5(3): 77–85.

Dimachkie M, Barohn R. Inclusion Body Myositis. Semin Neurol 2012; 32(3): 237‒45.

Garlepp MJ, Mastaglia FL. Inclusion body myositis: new in-sights into pathogenesis. Curr Opin Rheumatol 2008; 20(6): 662‒8.

Dalakas MC. Sporadic inclusion body myositis – diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006; 2(8): 437‒47.

Needham M, Mastaglia FL. Sporadic inclusion body myositis: a continuing puzzle. Neuromuscul Disord 2008; 18(1): 6‒16.

Dalakas MC. Inflammatory, immune and viral aspects of in-clusion-body myositis. Neurology 2006; 66(2 Suppl 1): S33‒8.

Engel WK, Askanas V. Inclusion-body myositis. Clinical, di-agnostic, and pathologic aspects. Neurology 2006; 66(2 Suppl 1): 20‒9.

Shams F, Cauchi P. Lagophthalmos and Ptosis in Inclusion Body Myositis. Ophthal Plast Reconstr Surg 2017; 33(3S Suppl 1): S161‒2.

Mastaglia FL, Needham M. Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and thera-peutic approaches. J Clin Neurosci 2015; 22(1): 6‒13.

Iaccarino L, Shoenfeld N, Rampudda M, Zen M, Gatto M, Ghirardello A, et al. The olfactory function is impaired in pa-tients with idiopathic inflammatory myopathies. Immunol Res 2014; 60(2‒3): 247‒52.

De Andrade DC, de Magalhães Souza SC, de Carvalho JF, Taka-yama L, Borges CT, Aldrighi JM, et al. High frequency of os-teoporosis and fractures in women with dermatomyo-sitis/polymyositis. Rheumatol Int 2012; 32(6): 1549‒53.

Alfano LN, Lowes LP, Dvorchik I, Yin H, Maus EG, Flanigan KM, et al. The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion bodymyositis. Neu-romuscul Disord 2014; 24(3): 222‒6.

Lundberg IE, Vencovsky J, Alexanderson H. Therapy of myo-sitis: biological and physical. Curr Opin Rheumatol 2014; 26(6): 704‒11.

Alexanderson H. Exercise in Inflammatory Myopathies, In-cluding Inclusion Body Myositis. Curr Rheumatol Rep 2012; 14(3): 244‒51.

Machado PM, Ahmed M, Brady S, Gang Q, Healy E, Morrow JM, et al. Ongoing developments in sporadic inclusion body myositis. Curr Rheumatol Rep 2014; 16(12): 477.

Objavljeno
2020/12/08
Broj časopisa
Vol. 77 Br. 11 (2020): Vojnosanitetski pregled
Rubrika
Prikaz bolesnika